 A STUDY TO ASSESS THE EFFICACY AND SAFETY OF FARLETUZUMAB MORAB 003 IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL OR CARBOPLATIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN PLD IN SUBJECTS WITH LOW CA125 PLATINUM-SENSITIVE OVARIAN CANCER: 